ferric citrate has been researched along with calcium acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE | 1 |
| Berner, T; Dieguez, G; Ferro, C; Kovesdy, CP; Metz, S; Moore, J; Szabo, E | 1 |
1 trial(s) available for ferric citrate and calcium acetate
| Article | Year |
|---|---|
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2015 |
1 other study(ies) available for ferric citrate and calcium acetate
| Article | Year |
|---|---|
Real-World Phosphate Binder Use among Dialysis-Dependent Patients with CKD.
Topics: Aged; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Medicare; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; United States | 2023 |